Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Pharmaceuticals, Biotechnology & Life Sciences Average - - - - - - 14,617.43 7,940.71 -734.00 6,293.14 -105.29 0.00 3.0877 -2.24 0.2314 -0.0135 -0.02 -0.08 1.1306 - -
Maximum - - - - - - 79,102.00 37,052.00 599.00 26,448.00 489.00 0.02 31.9262 1.31 0.6895 0.2735 0.04 0.12 1.7119 - -
Minimum - - - - - - 404.00 372.00 -5,907.00 -501.00 -989.00 0.00 -37.1303 -6.85 0.0558 -0.1594 -0.07 -0.44 0.2760 - -
Blueprint Medicines Corporation BPMC 98.09 1.21 1.25% 89 vs. 602 6,231.00 96.00 89.00 -102.00 -2,250.00 1.4500 16.6530 0.0000 0.9168 0.9274 0.2869 0.0858 3.4266 63.00
United Therapeutics Corporation UTHR 397.09 -3.36 -0.84% 36 vs. 392 17,727.00 677.00 306.00 338.00 6,333.00 6.5200 8.7477 0.0000 0.8924 0.4524 0.0574 0.0472 3.5035 44.00
Incyte Corporation INCY 79.55 -0.93 -1.16% 242 vs. 1,865 15,325.00 880.00 169.00 209.00 329.00 0.7600 18.7480 0.0000 0.9308 0.1925 0.0314 0.0238 3.2913 192.00
Alnylam Pharmaceuticals, Inc. ALNY 262.47 -2.13 -0.81% 102 vs. 824 33,853.00 494.00 -65.00 -94.00 -7,075.00 -0.5200 -73.3326 0.0000 0.8665 -0.1334 0.3007 -0.0172 2.8593 128.00
Apellis Pharmaceuticals, Inc. APLS 28.23 -0.02 -0.05% 683 vs. 2,426 3,512.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 124.00
Seagen Inc. SGEN 228.74 -0.16 -0.07% 19,392 vs. 1,634 43,154.00 648.00 -215.00 -79.00 -2,756.00 -1.1500 -46.2406 0.0000 0.7452 -0.3327 -0.0846 -0.0594 1.9572 188.00
Madrigal Pharmaceuticals, Inc. MDGL 314.03 -1.12 -0.36% 101 vs. 354 6,849.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.0000 0.0000 0.0000 -0.1734 -0.1363 9.2623 21.00
Karuna Therapeutics, Inc. KRTX 329.83 0.09 0.03% 1,283 vs. 971 12,599.00 0.00 -113.00 -111.00 -997.00 -3.0100 -26.2644 0.0000 0.0000 0.0000 -0.0908 -0.0852 18.6075 38.00
Krystal Biotech, Inc. KRYS 183.60 -0.62 -0.34% 31 vs. 217 5,280.00 45.00 0.00 14.00 -268.00 0.0300 1336.3467 0.0000 0.9465 0.0206 0.0012 0.0011 12.2870 28.00
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.0000 0.9628 8.4849 2.2110 0.3840 2.8209 38.00
BioMarin Pharmaceutical Inc. BMRN 66.28 -0.38 -0.56% 223 vs. 1,764 12,632.00 648.00 88.00 12.00 -532.00 0.4700 46.3847 0.0000 0.7850 0.1366 0.0175 0.0129 1.5477 190.00
Ultragenyx Pharmaceutical Inc. RARE 48.49 -0.22 -0.45% 56 vs. 719 4,477.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.0000 0.7576 -1.5683 -1.2169 -0.1306 2.1127 92.00
IVERIC bio, Inc. ISEE 39.95 0.15 0.38% 10,801 vs. 4,945 5,512.00 0.00 -70.00 -50.00 -937.00 -0.5200 -11.8078 0.0000 0.0000 0.0000 -0.1480 -0.1151 15.2365 137.00
Halozyme Therapeutics, Inc. HALO 58.70 0.10 0.16% 126 vs. 1,369 7,468.00 195.00 76.00 125.00 167.00 0.6100 17.0691 0.0000 0.7647 0.3922 0.4321 0.0417 5.0088 127.00
Exelixis, Inc. EXEL 35.40 0.21 0.58% 441 vs. 2,028 10,108.00 425.00 37.00 50.00 -258.00 0.1200 47.8131 0.0000 0.9500 0.0878 0.0175 0.0133 3.2273 285.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for 0HD2.L and its peers to uncover potential buy and sell opportunities.